R3T is an investigational peptide designed to activate GIP, GLP-1 and glucagon receptors. It is being studied in controlled clinical programmes for weight, appetite and wider metabolic outcomes.
- Composition
- R3T 40 mg
- Presentation
- 40 mg / 3 mL
- Research focus
- GIP, GLP-1 and glucagon signalling · Appetite pathways · Weight outcomes · Metabolic control

